You Won’t Believe What West Ham Just Pulled Off on Friday – Insanely Lucrative Deal Signed, Medical Smashed, and the Entire Club Is Going ABSOLUTELY WILD in Epic January Celebration! Hammers Fans Are Losing Their Minds Over This Game-Changing Transfer Bombshell!

Lazio forward Taty Castellanos has reportedly taken a major step towards completing a move to West Ham United after travelling to London on Friday to undergo a medical and finalise personal terms on a lucrative long-term contract.

According to Corriere dello Sport, the transfer is now at an advanced stage, with the Argentine striker having already completed his medical checks before putting pen to paper on a four-year deal with the Premier League club.

West Ham are understood to have agreed a fee of €29 million to secure his services from Lazio during the January transfer window.

The Italian outlet explains that Castellanos’ overall profile strongly appealed to West Ham’s recruitment team, who are keen to reshape their attacking options.

Alongside Castellanos, the Hammers have also completed the signing of Pablo Felipe from Gil Vicente, highlighting a clear focus on reinforcing the forward line.

It is believed Castellanos’ mobility, work rate, and movement in the final third fit the type of striker head coach Nuno Espirito Santo is looking for.

However, questions remain over whether he can finally help the club overcome their long-standing struggles in the number nine position.

Some observers have suggested the move could be viewed as a typical January panic signing, especially considering West Ham’s current league position.

From Lazio’s perspective, though, the deal represents excellent business, having signed Castellanos for €15 million back in 2023.

The transfer is also set to benefit Universidad de Chile, who will receive around €300,000 through FIFA’s Solidarity Scheme.

The Chilean club is entitled to 1% of the fee, as Castellanos progressed through their youth system before leaving in 2018, allowing them to share in the proceeds of West Ham’s latest attacking investment.